1. Molecular Cancer Research 2. Financial Assistance to those in need that have been diagnosed, must fill out application to qualify. Molecular Cancer Research At this time there are only two companies that conduct research. For more information and new developments visit www.biooncology.com
Leading in innovation by following the science. While there are many distinct types of cancer, there are believed to be 5 essential alterations to normal cell physiology, which together define the progression of most human malignancies.
Our goal at Genentech, a member of the Roche Group, is to investigate and develop innovative therapies that target the biologic mechanisms that give rise to cancer, with the hope of extending the lives of patients. Our scientists are dedicated to defining the molecular basis of cancer and to translating this knowledge into the development of novel biologic and small-molecule agents that target the ability of cancer cells to grow and spread.
Your dollar goes farther with CHC: We are committed to $0.80 of every dollar CHC spent goes directly to program services, financial assistance for those diagnosed and their families and molecular cancer research.
Promote health and good morale for your employees: Chances are, two out of five people who work for your organization will be diagnosed with cancer at some point in their life. Working alongside CHC, you can help save the lives of people with whom you work daily.
Generate more customers: Studies show that consumers prefer purchasing things from companies known to be charitable. This will align your company with a disease that affects hundreds of thousands of people each year.
100% of us will be touched by cancer in some form.